Previous close | 21.79 |
Open | 21.85 |
Bid | 22.10 x 90000 |
Ask | 22.28 x 90000 |
Day's range | 21.85 - 21.85 |
52-week range | 16.49 - 22.00 |
Volume | |
Avg. volume | 58 |
Market cap | 6.513B |
Beta (5Y monthly) | 0.57 |
PE ratio (TTM) | 35.82 |
EPS (TTM) | 0.61 |
Earnings date | 30 Apr 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 31.83 |
Immunome (IMNM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Merus (MRUS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
EXEL vs. REGN: Which Stock Is the Better Value Option?